ArticleArXiv2025
Alterations of brain tissue structural complexity and disorder in Alzheimer's disease (AD): Fractal, multifractal, fractal transformation, and disorder strength analyses.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alzheimer's disease (AD) is characterized by progressive microstructural deterioration in brain tissue, yet conventional imaging and histopathology often lack the sensitivity needed to detect subtle early-stage changes. Here, we present a multiparametric framework combining fractal and multifractal analysis and their distributions to quantify structural alterations in human brain tissue affected by AD. Moreover, from the fractal and multifractal formalism, we introduced an innovative fractal functional distribution method, a novel technique that transforms fractal distribution into a Gaussian form. Statistically, these distribution parameters are easy to interpret and can distinguish between control and diseased tissues. Across samples, we identify pronounced threshold-dependent behavior of fractal and multifractal parameters, reflecting the intrinsic sparsity and heterogeneous intensity landscape of brain tissue. These threshold-sensitive signatures provide a framework for quantitative stage detection and may serve as biomarkers for early pathological transitions. In addition, we studied structural disorder and complexity using our established light localization technique, inverse participation ratio (IPR) analysis. IPR-based analysis demonstrates that increasing IPR pixel size highlights the elevation of structural alterations with disease progression. Together, these integrative analyses establish a robust, multi-scale quantitative framework for detecting microstructural alterations in AD, providing a promising foundation for early diagnosis and improved pathological assessment.
Indexed as
Identifiers
41415610PMC12709484What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.